Clinical Trial Update: Safety Evaluation of Telmisartan Plus Hydrochlorothiazide in Patients With Mild-to-Moderate Hypertension [Phase 3]

View source ↗

Summary

Phase 3 safety evaluation of telmisartan plus hydrochlorothiazide in patients with mild-to-moderate hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Telmisartan plus hydrochlorothiazide (telmisartan/hydrochlorothiazide)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Phase 3 | Status: COMPLETED